chr10-102401801-G-A
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2
The NM_001322934.2(NFKB2):c.2350G>A(p.Gly784Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000564 in 1,613,742 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Uncertain significance in ClinVar.
Frequency
Consequence
NM_001322934.2 missense
Scores
Clinical Significance
Conservation
Publications
- immunodeficiency, common variable, 10Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Ambry Genetics
- common variable immunodeficiencyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- deficiency in anterior pituitary function - variable immunodeficiency syndromeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000210 AC: 32AN: 152212Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.0000523 AC: 13AN: 248550 AF XY: 0.0000667 show subpopulations
GnomAD4 exome AF: 0.0000404 AC: 59AN: 1461412Hom.: 0 Cov.: 34 AF XY: 0.0000399 AC XY: 29AN XY: 726998 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000210 AC: 32AN: 152330Hom.: 0 Cov.: 33 AF XY: 0.000228 AC XY: 17AN XY: 74494 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
The c.2350G>A (p.G784R) alteration is located in exon 21 (coding exon 20) of the NFKB2 gene. This alteration results from a G to A substitution at nucleotide position 2350, causing the glycine (G) at amino acid position 784 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Immunodeficiency, common variable, 10 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at